Cargando…

Estimated impact of RTS,S/AS01 malaria vaccine allocation strategies in sub-Saharan Africa: A modelling study

BACKGROUND: The RTS,S/AS01 vaccine against Plasmodium falciparum malaria infection completed phase III trials in 2014 and demonstrated efficacy against clinical malaria of approximately 36% over 4 years for a 4-dose schedule in children aged 5–17 months. Pilot vaccine implementation has recently beg...

Descripción completa

Detalles Bibliográficos
Autores principales:	Hogan, Alexandra B., Winskill, Peter, Ghani, Azra C.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2020
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7703928/ https://www.ncbi.nlm.nih.gov/pubmed/33253211 http://dx.doi.org/10.1371/journal.pmed.1003377

Ejemplares similares

Modelling the cost-effectiveness of introducing the RTS,S malaria vaccine relative to scaling up other malaria interventions in sub-Saharan Africa
por: Winskill, Peter, et al.
Publicado: (2017)

Modelling the roles of antibody titre and avidity in protection from Plasmodium falciparum malaria infection following RTS,S/AS01 vaccination
por: Thompson, Hayley A., et al.
Publicado: (2020)

Current challenges and proposed solutions to the effective implementation of the RTS, S/AS01 Malaria Vaccine Program in sub-Saharan Africa: A systematic review
por: Dimala, Christian Akem, et al.
Publicado: (2018)

The thermostability of the RTS,S/AS01 malaria vaccine can be increased by co-lyophilizing RTS,S and AS01
por: Fortpied, Juliette, et al.
Publicado: (2020)

Safety and immunogenicity of the RTS,S/AS01 malaria vaccine in infants and children identified as HIV-infected during a randomized trial in sub-Saharan Africa
por: Otieno, Lucas, et al.
Publicado: (2020)

Estimates of the changing age-burden of Plasmodium falciparum malaria disease in sub-Saharan Africa
por: Griffin, Jamie T., et al.
Publicado: (2014)

The Costs of Implementing Vaccination With the RTS,S Malaria Vaccine in Five Sub-Saharan African Countries
por: Sicuri, Elisa, et al.
Publicado: (2019)

Potential public health impact of RTS,S malaria candidate vaccine in sub-Saharan Africa: a modelling study
por: Sauboin, Christophe J., et al.
Publicado: (2015)

Safety profile of the RTS,S/AS01 malaria vaccine in infants and children: additional data from a phase III randomized controlled trial in sub-Saharan Africa
por: Guerra Mendoza, Yolanda, et al.
Publicado: (2019)

False-negative malaria rapid diagnostic test results and their impact on community-based malaria surveys in sub-Saharan Africa
por: Watson, Oliver J, et al.
Publicado: (2019)

Analysis of the potential for a malaria vaccine to reduce gaps in malaria intervention coverage
por: Unwin, H. Juliette T., et al.
Publicado: (2021)

The Future of the RTS,S/AS01 Malaria Vaccine: An Alternative Development Plan
por: Gosling, Roly, et al.
Publicado: (2016)

Implementation strategies for the introduction of the RTS,S/AS01 (RTS,S) malaria vaccine in countries with areas of highly seasonal transmission: workshop meeting report
por: Merle, Corinne S.
Publicado: (2023)

Baseline incidence of meningitis, malaria, mortality and other health outcomes in infants and young sub-Saharan African children prior to the introduction of the RTS,S/AS01(E) malaria vaccine
Publicado: (2021)

Environmental modifiers of RTS,S/AS01 malaria vaccine efficacy in Lilongwe, Malawi
por: Bell, Griffin J., et al.
Publicado: (2020)

Towards Eradication of Malaria: Is the WHO’s RTS,S/AS01 Vaccination Effective Enough?
por: Arora, Navneet, et al.
Publicado: (2021)

Should India be considering deployment of the first malaria vaccine RTS, S/AS01?
por: Rahi, Manju, et al.
Publicado: (2022)

RTS,S/AS01 Malaria Vaccine - The Next Step for a Developing Country
por: ZEHRA, ASMAT, et al.
Publicado: (2022)

RTS,S/AS01 malaria vaccine (Mosquirix(®)): a profile of its use
por: Syed, Yahiya Y.
Publicado: (2022)

Acceptance, availability, and feasibility of RTS, S/AS01 malaria vaccine: A review
por: Mumtaz, Hassan, et al.
Publicado: (2023)

Correction to: Baseline incidence of meningitis, malaria, mortality and other health outcomes in infants and young sub-Saharan African children prior to the introduction of the RTS,S/AS01(E) malaria vaccine
por: Haine, Valérie
Publicado: (2021)

Modelling population-level impact to inform target product profiles for childhood malaria vaccines
por: Hogan, Alexandra B., et al.
Publicado: (2018)

Cost of introducing and delivering RTS,S/AS01 malaria vaccine within the malaria vaccine implementation program
por: Baral, Ranju, et al.
Publicado: (2023)

Simulated Impact of RTS,S/AS01 Vaccination Programs in the Context of Changing Malaria Transmission
por: Brooks, Alan, et al.
Publicado: (2012)

Assessing the safety, impact and effectiveness of RTS,S/AS01(E) malaria vaccine following its introduction in three sub-Saharan African countries: methodological approaches and study set-up
por: Praet, Nicolas, et al.
Publicado: (2022)

Evaluation of RTS,S/AS02A and RTS,S/AS01B in Adults in a High Malaria Transmission Area
por: Polhemus, Mark E., et al.
Publicado: (2009)

RTS,S/AS01 malaria vaccine mismatch observed among Plasmodium falciparum isolates from southern and central Africa and globally
por: Pringle, Julia C., et al.
Publicado: (2018)

Public health impact and cost-effectiveness of the RTS,S/AS01 malaria vaccine: a systematic comparison of predictions from four mathematical models
por: Penny, Melissa A, et al.
Publicado: (2016)

The Anti-Circumsporozoite Antibody Response of Children to Seasonal Vaccination With the RTS,S/AS01(E) Malaria Vaccine( )
por: Sagara, Issaka, et al.
Publicado: (2021)

RTS,S: the first malaria vaccine
por: Zavala, Fidel
Publicado: (2022)

T Cell Responses to the RTS,S/AS01(E) and RTS,S/AS02(D) Malaria Candidate Vaccines Administered According to Different Schedules to Ghanaian Children
por: Ansong, Daniel, et al.
Publicado: (2011)

Impact of RTS,S/AS02(A) and RTS,S/AS01(B) on Genotypes of P. falciparum in Adults Participating in a Malaria Vaccine Clinical Trial
por: Waitumbi, John N., et al.
Publicado: (2009)

Impact of high human genetic diversity in Africa on immunogenicity and efficacy of RTS,S/AS01 vaccine
por: Tukwasibwe, Stephen, et al.
Publicado: (2023)

Mosquirix™ RTS, S/AS01 Vaccine Development, Immunogenicity, and Efficacy
por: Nadeem, Aroosa Younis, et al.
Publicado: (2022)

Randomized Controlled Trial of RTS,S/AS02(D) and RTS,S/AS01(E) Malaria Candidate Vaccines Given According to Different Schedules in Ghanaian Children
por: Owusu-Agyei, Seth, et al.
Publicado: (2009)

Efficacy of RTS,S malaria vaccines: individual-participant pooled analysis of phase 2 data
por: Bejon, Philip, et al.
Publicado: (2013)

The biological function of antibodies induced by the RTS,S/AS01 malaria vaccine candidate is determined by their fine specificity
por: Chaudhury, Sidhartha, et al.
Publicado: (2016)

Potential effect modification of RTS,S/AS01 malaria vaccine efficacy by household socio-economic status
por: Gyaase, Stephaney, et al.
Publicado: (2021)

A Phase IIa Controlled Human Malaria Infection and Immunogenicity Study of RTS,S/AS01(E) and RTS,S/AS01(B) Delayed Fractional Dose Regimens in Malaria-Naive Adults
por: Moon, James E, et al.
Publicado: (2020)

The Clinical Profile of Severe Pediatric Malaria in an Area Targeted for Routine RTS,S/AS01 Malaria Vaccination in Western Kenya
por: Akech, Samuel, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_8q8in173saurcd0cnon6sncnn6